Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Combining Ribozero and PolyA data

    Hi everyone,

    I performed mapping and differential expression analysis of PolyA selected RNASeq libraries and now I'm going to get more samples prepared using Ribo-Zero.
    Is there a safe way to combine the two datasets and run a new analysis on the extended dataset?

  • #2
    I'd include a few replicates (same RNA sample prepped with both protocols) and see what differences come out.

    Why not stick with the same protocol as before?

    Comment


    • #3
      Thank you for your answer. Unfortunately the libraries have already been made and it's not possible to include replicates from the previous library. I am only performing the bioinformatics analysis.
      So I was wondering if it's possible to combine the two libraries somehow in order to have a bigger set.

      Comment


      • #4
        I wouldn't be comfortable directly comparing samples with different preparation methods. However, if you're imposing rather high fold ratios when considering differential expression, and will perform downstream validation (e.g. RT-qPCR), I guess you could live with it.

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Understanding Genetic Influence on Infectious Disease
          by seqadmin




          During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

          Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
          09-09-2024, 10:59 AM
        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, Today, 06:25 AM
        0 responses
        13 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, Yesterday, 01:02 PM
        0 responses
        12 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-18-2024, 06:39 AM
        0 responses
        14 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-11-2024, 02:44 PM
        0 responses
        14 views
        0 likes
        Last Post seqadmin  
        Working...
        X